GKCC LLC 13D and 13G filings for Elicio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-14 5:01 pm Purchase | 2024-08-12 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC LLC | 5,595,108 38.700% | 3,442,341 (+159.90%) | Filing |
| 2024-07-02 4:39 pm Purchase | 2024-06-28 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC LLC | 2,152,767 19.990% | 109,587 (+5.36%) | Filing |
| 2024-03-20 4:37 pm Purchase | 2024-03-19 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC LLC | 2,043,180 19.990% | 123,016 (+6.41%) | Filing |
| 2023-12-26 4:25 pm Purchase | 2023-12-22 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC LLC | 1,920,164 19.990% | 1,213,000 (+171.53%) | Filing |
| 2023-06-14 2:42 pm Purchase | 2023-06-01 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC LLC | 707,164 8.400% | 707,164 (New Position) | Filing |